TUHURA BIOSCIENCES INC (HURA) Stock News

USA - NASDAQ:HURA - US8989201038 - Common Stock

2.56 USD

+0.03 (+1.19%)

Last: 10/15/2025, 4:18:35 PM

2.56 USD

0 (0%)

After Hours: 10/15/2025, 4:18:35 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

HURA Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference

2 months ago - By: The Motley Fool

TuHURA R&D Jumps 75% in Q2

2 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

2 months ago - By: Benzinga - Mentions: ARCT LIXT DERM EDIT ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2 months ago - By: Benzinga - Mentions: BABA

Florida Rep. Laurel Lee Sold Up to $265K Worth of Alibaba Gr Hldgs Stock

7 months ago - By: ACCESS Newswire

TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

8 months ago - By: ACCESS Newswire

TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

4 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

4 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences Completes Acquisition of Kineta

4 months ago - By: Stocktwits

Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline

4 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals

4 months ago - By: Halper Sadeh LLP - Mentions: VIGL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

4 months ago - By: TuHURA Biosciences, Inc.

FDA Removes Partial Clinical Hold on TuHURA Biosciences' Phase 3 Accelerated Approval Trial for IFx-2.0 in Advanced or Metastatic Merkel Cell Carcinoma

4 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Enters into $12.5 Million Equity Financing Transaction and Receives Additional $3.0 Million in Warrant Exercise Proceeds to Advance Its Pipeline of Novel Treatments to Overcome Primary Resistance to Cancer Immunotherapy

5 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences Presents IFx-Hu2.0 Trial-in-Progress Poster at the 2025 American Society of Clinical Oncology Annual Meeting

5 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

5 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. to Present at the 3rd Annual H.C. Wainwright BioConnect Conference

6 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual

6 months ago - By: Yahoo Finance - Mentions: MTCH COMP NWG KMX ...

Match Group, Inc. (MTCH): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

6 months ago - By: Yahoo Finance - Mentions: COMP MTCH HFFG THTX ...

Is TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?

6 months ago - By: Yahoo Finance - Mentions: MBOT HFFG COMP RGLS ...

Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts?

6 months ago - By: Yahoo Finance - Mentions: ITRG GSC HES COMP ...

Is Integra Resources Corp. (ITRG) the Best Rising Penny Stock to Buy According to Analysts?

6 months ago - By: Yahoo Finance - Mentions: SATX MBOT COMP MTCH ...

Is Satixfy Communications Ltd. (SATX) the Best Rising Penny Stock to Buy According to Analysts?

6 months ago - By: Yahoo Finance - Mentions: HFFG CRL COMP MBOT ...

Is HF Foods Group Inc. (HFFG) the Best Rising Penny Stock to Buy According to Analysts?

6 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management

7 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

7 months ago - By: ACCESS Newswire

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

10 months ago - By: Halper Sadeh LLC - Mentions: VTS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders

10 months ago - By: Halper Sadeh LLC - Mentions: PFIE ML KANT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, ML, HURA, KANT on Behalf of Shareholders

10 months ago - By: Halper Sadeh LLC - Mentions: ML PDCO KANT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders